Stelexis Therapeutics
Jiahao is a talented molecular biologist and stem cell expert with over 10 years of experience in the cancer genomics and biomarker space. During his time at BGI, he focused on oncology biomarker discovery. Jiahao graduated with his Ph.D. from Albert Einstein College of Medicine, where he extensively studied the mechanism of leukemic stem cells formation. He joined Stelexis in March 2019 as a Senior Scientist and is currently leading the cancer stem cell platform development and validation efforts.
Stelexis Therapeutics
Stelexis is a Deerfield founded and solely funded New York-based cancer therapeutics company with a mission of transforming cancer therapeutics paradigm and patient care, through the discovery and development of novel drugs.